TWO SIGMA ADVISERS, LP - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 215 filers reported holding MYRIAD GENETICS INC in Q3 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$506,864
+1.7%
31,600
+47.0%
0.00%0.0%
Q2 2023$498,370
-13.5%
21,500
-13.3%
0.00%0.0%
Q1 2023$576,104
+20.7%
24,800
-24.6%
0.00%0.0%
Q4 2022$477,379
-29.2%
32,900
-6.8%
0.00%
-50.0%
Q3 2022$674,000
-11.7%
35,300
-16.0%
0.00%0.0%
Q2 2022$763,000
-47.5%
42,000
-27.2%
0.00%
-50.0%
Q1 2022$1,454,000
-31.6%
57,700
-25.1%
0.00%
-20.0%
Q4 2021$2,125,000
-48.4%
77,000
-39.6%
0.01%
-54.5%
Q3 2021$4,117,000
-65.0%
127,500
-66.8%
0.01%
-64.5%
Q2 2021$11,749,000
-35.4%
384,200
-35.7%
0.03%
-38.0%
Q1 2021$18,197,000
+26.4%
597,600
-17.9%
0.05%
+31.6%
Q4 2020$14,402,000
+28.9%
728,300
-15.0%
0.04%
+18.8%
Q3 2020$11,170,000
+59.4%
856,600
+38.6%
0.03%
+52.4%
Q2 2020$7,007,000
+360.1%
617,900
+480.7%
0.02%
+250.0%
Q1 2020$1,523,000
+360.1%
106,400
+794.1%
0.01%
+500.0%
Q2 2019$331,000
+45.8%
11,900
+52.6%
0.00%0.0%
Q4 2018$227,000
-20.9%
7,800
-19.6%
0.00%0.0%
Q1 2018$287,000
-97.0%
9,698
-96.5%
0.00%
-96.2%
Q4 2017$9,627,000
-47.5%
280,312
-44.7%
0.03%
-50.0%
Q3 2017$18,338,000
+31.1%
506,860
-6.4%
0.05%
+13.0%
Q2 2017$13,987,000
-11.5%
541,290
-34.2%
0.05%
-11.5%
Q1 2017$15,804,000
-9.5%
823,112
-21.4%
0.05%
-22.4%
Q4 2016$17,468,000
+31.0%
1,047,867
+61.7%
0.07%
+17.5%
Q3 2016$13,338,000
-6.7%
648,083
+38.7%
0.06%
-21.9%
Q2 2016$14,302,000
+12.6%
467,399
+37.8%
0.07%
+2.8%
Q1 2016$12,696,000
-10.5%
339,199
+3.3%
0.07%
-15.5%
Q4 2015$14,178,000
+45.7%
328,499
+26.5%
0.08%
+37.7%
Q3 2015$9,734,000
+11.0%
259,699
+0.7%
0.06%
-9.0%
Q2 2015$8,769,000
+4.5%
257,999
+8.8%
0.07%
+4.7%
Q1 2015$8,393,000
+3.9%
237,099
-0.0%
0.06%
-1.5%
Q4 2014$8,079,000
-48.4%
237,199
-41.5%
0.06%
-47.2%
Q3 2014$15,652,000
-17.5%
405,799
-16.8%
0.12%
-16.9%
Q2 2014$18,981,000
-11.5%
487,699
-22.2%
0.15%
-24.1%
Q1 2014$21,445,000
+169.3%
627,199
+65.2%
0.20%
+153.2%
Q4 2013$7,964,000
+233.5%
379,599
+273.6%
0.08%
+175.0%
Q3 2013$2,388,000
+1053.6%
101,599
+1216.2%
0.03%
+833.3%
Q2 2013$207,0007,7190.00%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
SCOPIA CAPITAL MANAGEMENT LP 6,459,139$278,776,0005.53%
Tieton Capital Management, LLC 119,290$5,149,0004.04%
RPg Family Wealth Advisory, LLC 97,202$4,195,238,0003.85%
RK Capital 384,900$16,612,0002.90%
Contrarius Investment Management Ltd 652,288$28,153,0002.65%
S&T BANK/PA 331,885$14,324,0002.22%
Euclidean Technologies Management, LLC 40,917$1,766,0001.90%
AIMZ Investment Advisors, LLC 45,635$1,970,0001.80%
Taylor Frigon Capital Management LLC 34,783$1,486,0001.67%
KILLEN GROUP INC 366,305$15,810,0001.63%
View complete list of MYRIAD GENETICS INC shareholders